Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Akari Tanaka"'
Autor:
Shota Ito, Yuichi Mine, Yuki Yoshimi, Saori Takeda, Akari Tanaka, Azusa Onishi, Tzu-Yu Peng, Takashi Nakamoto, Toshikazu Nagasaki, Naoya Kakimoto, Takeshi Murayama, Kotaro Tanimoto
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Temporomandibular disorders are typically accompanied by a number of clinical manifestations that involve pain and dysfunction of the masticatory muscles and temporomandibular joint. The most important subgroup of articular abnormalities in
Externí odkaz:
https://doaj.org/article/9cb6b6bb76c641cba27ddb530a0b38da
Publikováno v:
Therapeutic Innovation & Regulatory Science. 56:85-95
The utilization of biomarkers has become increasingly active to enhance efficiency of clinical development. This study evaluated the current situation and quantitative impact of co-development of companion diagnostics (CDx) on the oncology drug devel
Autor:
Tzu-Yu Peng, Yuichi Mine, Akari Tanaka, Saori Takeda, Kotaro Tanimoto, Shota Ito, Toshikazu Nagasaki, Naoya Kakimoto, Takeshi Murayama, Takashi Nakamoto, Yuki Yoshimi, Azusa Onishi
Temporomandibular disorders are typically accompanied by a number of clinical manifestations that involve pain and dysfunction of the masticatory muscles and temporomandibular joint. The most important subgroup of articular abnormalities in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3e623a6d117d5dc3085b2f253e7c8bb
https://doi.org/10.21203/rs.3.rs-519580/v1
https://doi.org/10.21203/rs.3.rs-519580/v1
Publikováno v:
Therapeutic innovationregulatory science. 56(1)
The utilization of biomarkers has become increasingly active to enhance efficiency of clinical development. This study evaluated the current situation and quantitative impact of co-development of companion diagnostics (CDx) on the oncology drug devel
Autor:
Chihiro Endo-Tsukude, Toshihiko Doi, Yutaka Fujiwara, Satoru Iwasa, Nobuaki Matsubara, Junichi Tomomatsu, Shintaro Nakagawa, Shunji Takahashi, Akari Tanaka
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose Ipatasertib is a selective inhibitor of Akt, a frequently activated protein kinase in human cancers. The current study assessed the safety, tolerability, and pharmacokinetics of ipatasertib in Japanese patients with solid tumors. Methods This
Autor:
Akari, Tanaka1
Publikováno v:
Japanese Journal of Developmental Psychology / Hattatsu Shinrigaku Kenkyū. Mar2013, Vol. 24 Issue 1, p42-54. 13p. 1 Diagram, 5 Charts.
Autor:
Masaharu Ito, Akari Tanaka-Shiraishi, Takashi Matsumoto, Masaki Kiyomura, Yasuki Kusanagi, Tomihiro Katayama
Publikováno v:
American Journal of Obstetrics and Gynecology. 191:322-327
Objective The accumulation of evidence implicates oxidized lipoproteins in atherosclerosis. Treatment of endothelial cells with these lipoproteins stimulates monocyte binding and the production of chemotactic factors that contribute to inflammation a
Autor:
Akari Tanaka, Toshiro Miyahara
Publikováno v:
JOURNAL OF CHEMICAL ENGINEERING OF JAPAN. 30:353-355
The aim of this paper is to experimentally investigate the size of bubbles from sintered mesh plates and sintered metal particle plates. In addition, the results will be compared with those obtained by the authors (Miyahara et al., 1983).